Social media

Meet the ICON Biotech team at #ESMO25, booth #3034 to discover how our collaborative, agile, and science-driven team partners with biotech sponsors to navigate complexity and accelerate oncology clinical development—from...

Innovation, collaboration, and insight come together at #SCDMUS, and ICON is excited to be part of it. From 27–30 September at the Baltimore Convention Center, our team will be on hand at booth 308 to connect and showcas...

Innovation, collaboration, and insight come together at #SCDMUS, and ICON is excited to be part of it. From 27–30 September at the Baltimore Convention Center, our team will be on hand at booth 308 to connect and showcas...

Explore our case study library to see how we help sponsors overcome obesity trial challenges with our industry-leading, flexible, end-to-end clinical development solutions. https://ow.ly/hecg50WY1be

Explore our case study library to see how we help sponsors overcome obesity trial challenges with our industry-leading, flexible, end-to-end clinical development solutions. https://ow.ly/B3VY50WY1bi

Why wait months when you can get results in weeks? Our real-time GMP manufacturing and clinical testing process accelerates decision-making, saving time and costs while improving early phase trial outcomes. Let’s get...

Why wait months when you can get results in weeks? Our real-time GMP manufacturing and clinical testing process accelerates decision-making, saving time and costs while improving early phase trial outcomes. Let’s get...

In recognition of World Cancer Research Day which takes place on 24 September, we highlight the importance of oncology research and the efforts made to develop new, innovative therapies. However, on this day it's also im...

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most sustain...

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most susta...

ICON’s Victoria DeVeaugh-Geiss will participate in this panel hosted by Citeline, discussing how to embed risk-based strategies across clinical research. Don’t miss this opportunity to connect and learn. https://ow.ly/o9...

ICON’s Victoria DeVeaugh-Geiss will participate in this panel hosted by Citeline, discussing how to embed risk-based strategies across clinical research. Don’t miss this opportunity to connect and learn. https://ow.ly/Uf...